(c) 2024 PillSync.com

oxcarbazepine 600 MG Oral Tablet

1 INDICATIONS AND USAGE Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine tablets are indicated for: Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures Pediatrics: Monotherapy in the treatment of partial-onset seizures in children 4-16 years Adjunctive therapy in the treatment of partial-onset seizures in children 2-16 years ( 1 )

American Health Packaging


4 years ago OVAL BROWN B 294 oxcarbazepine 600 MG Oral Tablet

OVAL BROWN B 294

16 HOW SUPPLIED/STORAGE AND HANDLING

OXCARBAZEPINE Tablets, USP are provided as: 150 mg film-coated Tablets: beige, film-coated, modified oval shaped tablet, scored on both sides, debossed "B2 | 92" on one side and plain on the other side. Unit dose packages of 100 (10 x 10) NDC 68084-845-01 300 mg film-coated Tablets: beige, film-coated, modified oval shaped tablet, scored on both sides, debossed "B | 293" on one side and plain on the other side. Unit dose packages of 100 (10 x 10) NDC 68084-853-01 600 mg film-coated Tablets: beige, film-coated, modified oval shaped tablet, scored on both sides, debossed "B | 294" on one side and plain on the other side. Unit dose packages of 100 (10 x 10) NDC 68084-867-01 Store at 20°-25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken.


More pills like OVAL B 294












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site